Literature DB >> 18777390

Eimeria infection of chicken embryos: the effect of known anticoccidial drugs against E. tenella and E. mivati.

P L Long1, B J Millard.   

Abstract

The activity of nine anticoccidial drugs was investigated against Eimeria infections of chicken embryos. With Eimeria tenella, three parameters were used to assess the antiparasitic effects (a) mortality (b) focal lesions on the chorioallantoic membrane (CAM) and (c) oocyst production. Anticoccidial drugs against E. mivati were evaluated by estimating oocyst production only. Only three of the anticoccidials tested were found to have high activity when measured by all of the above criteria. All of the drugs tested reduced infections caused by E. tenella and E. mivati. With f. tenella, inhibition of CAM focal lesions and oocyst production proved to be more sensitive parameters than mortality of infected embryos. The number of sporozoites in the inoculating dose was important, particularly in the oocyst production studies because excessively large numbers of sporozoites did not result in high yields of oocysts. The application of chicken embryo infections with Eimeria for the study of anticoccidial drugs is discussed.

Entities:  

Year:  1973        PMID: 18777390     DOI: 10.1080/03079457309353789

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  3 in total

1.  Evaluation of anticoccidial drugs in chicken embryos.

Authors:  M Q Xie; T Fukata; J M Gilbert; L R McDougald
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Electrophoretic variation of enzymes: a further marker for genetic studies of the Eimeria.

Authors:  M W Shirley
Journal:  Z Parasitenkd       Date:  1978-09-04

3.  Embryonated chicken eggs as an alternative model for mixed Clostridium perfringens and Eimeria tenella infection in chickens.

Authors:  Alaa Aldin Alnassan; Awad Ali Shehata; Marianne Kotsch; Matthias Lendner; Arwid Daugschies; Berit Bangoura
Journal:  Parasitol Res       Date:  2013-03-21       Impact factor: 2.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.